MS4A2 (NP_000130, 1 a.a. ~ 59 a.a) partial recombinant protein with GST tag. The sequence is MDTESNRRANLALPQEPSSVPAFEVLEISPQEVSSGRLLKSASSPPLHTWLTVLKKEQE
Conjugate
Unconjugated
Target
Alternative Names
MS4A2; membrane-spanning 4-domains, subfamily A, member 2; APY; IGEL; IGER; ATOPY; FCERI; IGHER; MS4A1; FCER1B; high affinity immunoglobulin epsilon receptor subunit beta; igE Fc receptor subunit beta; high affinity IgE receptor beta subunit; immunoglobul
The allergic response involves the binding of allergen to receptor-bound IgE followed by cell activation and the release of mediators responsible for the manifestations of allergy. The IgE-receptor, a tetramer composed of an alpha, beta, and 2 disulfide-linked gamma chains, is found on the surface of mast cells and basophils. This gene encodes the beta subunit of the high affinity IgE receptor which is a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This family member is localized to 11q12, among a cluster of membrane-spanning 4A gene family members. Alternative splicing results in multiple transcript variants encoding distinct proteins. Additional transcript variants have been described but require experimental validation.
Pathway
Asthma; Fc epsilon RI signaling pathway; Fc epsilon receptor (FCERI) signaling; Immune System
Citations
Publication ()
Have you cited DPAB-DC958 in a publication? Let us know and earn a reward for your research.
My Review for Anti-MS4A2 (aa 1-59) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.